Slide 1 Br J Haematol. 2008 Jun;141(6):757-63 Slide 2 A review of guidelines and update in emerging therapies Brian Spoelhof, PharmD April 19, 2012 Slide 3  The presenter…

Slide 1 Cardiology Revision 2014 Dr P Banerjee Consultant Cardiologist University Hospitals Coventry & Warwickshire Slide 2  Picture slides  ECG reading  How…

Slide 1 SH 286002 AB MAR 2015 WATCHMAN TM Left Atrial Appendage Closure Device Clinical Data Overview SH 286002 AB MAR 2015 Slide 2 Agenda The Need for a Device-Based Alternative…

Slide 1 Helen Williams Consultant Pharmacist for CV Disease South London Slide 2 Slide 3  AF is the leading - and most preventable - cause of embolic stroke  Risk increases…

Slide 1 LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death Deep…

Slide 1 | The WOEST Trial: First randomised trial comparing two regimens with and without aspirin in patients on oral anticoagulant therapy undergoing coronary stenting Willem…

Prognosticating Common Neurological Disorders Vincent B. Macalintal, MD, FPNA Types of Stroke Ischemic 83% Hemorrhagic 17% Stroke : risk factors Well established hypertension…

âNo Needless Medication Errorsâ Gillian Honeywell, Chief Pharmacist NHS Isle of Wight Medication Errors do happen.. Facts and figures Medicines are the most frequently…

Robert T CVA SAMIR TURK, M.D. SYMPTOMS OF STROKES AND TIA PARALYSIS NUMBNESS LANGUAGE VISUAL ATAXIA VERTIGO CLINICAL PRESENTATION CORRELATES WITH OCCLUDED ARTERY KNOWLEDGE…

Clinical Impact of the IHS Anticoagulation Training Program USPHS Scientific and Training Symposium May 2010 LT Nicholas Sparrow, Pharm.D. PGY1 Pharmacy Practice Resident…